These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10211867)

  • 1. Effect of itraconazole on the pharmacokinetics of digoxin in guinea pigs.
    Nishihara K; Hibino J; Kotaki H; Sawada Y; Iga T
    Biopharm Drug Dispos; 1999 Apr; 20(3):145-9. PubMed ID: 10211867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of itraconazole on digoxin clearance in patients with congestive heart failure].
    Wakasugi H; Ishizuka R; Koreeda N; Yano I; Futami T; Nohara R; Sasayama S; Inui K
    Yakugaku Zasshi; 2000 Sep; 120(9):807-11. PubMed ID: 11019654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.
    Templeton IE; Thummel KE; Kharasch ED; Kunze KL; Hoffer C; Nelson WL; Isoherranen N
    Clin Pharmacol Ther; 2008 Jan; 83(1):77-85. PubMed ID: 17495874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models.
    Vossen M; Sevestre M; Niederalt C; Jang IJ; Willmann S; Edginton AN
    Theor Biol Med Model; 2007 Mar; 4():13. PubMed ID: 17386084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole decreases renal clearance of digoxin.
    Jalava KM; Partanen J; Neuvonen PJ
    Ther Drug Monit; 1997 Dec; 19(6):609-13. PubMed ID: 9421099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: implication of concentrative uptake of inhibitors into liver.
    Yamano K; Yamamoto K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1999 Mar; 27(3):395-402. PubMed ID: 10064572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole increases serum digoxin concentration.
    Partanen J; Jalava KM; Neuvonen PJ
    Pharmacol Toxicol; 1996 Nov; 79(5):274-6. PubMed ID: 8936563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclosporine A and itraconazole on permeability, biliary excretion and pharmacokinetics of amlodipine.
    Ni L; Yu X; Yu Q; Chen X; Jia L
    Drug Metab Lett; 2008 Aug; 2(3):163-8. PubMed ID: 19356088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.
    Maincent JP; Najvar LK; Kirkpatrick WR; Huang S; Patterson TF; Wiederhold NP; Peters JI; Williams RO
    Drug Dev Ind Pharm; 2017 Feb; 43(2):264-274. PubMed ID: 27645428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice.
    Kawahara M; Sakata A; Miyashita T; Tamai I; Tsuji A
    J Pharm Sci; 1999 Dec; 88(12):1281-7. PubMed ID: 10585223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment: possible mechanism of digoxin-itraconazole interaction.
    Ito S; Koren G
    Ann Pharmacother; 1997 Sep; 31(9):1091-2. PubMed ID: 9296256
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers.
    Tsutsumi K; Kotegawa T; Kuranari M; Otani Y; Morimoto T; Matsuki S; Nakano S
    J Clin Pharmacol; 2002 Oct; 42(10):1159-64. PubMed ID: 12362931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of quinidine on digoxin distribution and elimination in guinea pigs.
    Sato J; Sawada Y; Iga T; Hanano M
    J Pharm Sci; 1983 Oct; 72(10):1137-41. PubMed ID: 6644558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro analysis of itraconazole cis-diastereoisomers inhibition of nine cytochrome P450 enzymes: stereoselective inhibition of CYP3A.
    Krasulova K; Dvorak Z; Anzenbacher P
    Xenobiotica; 2019 Jan; 49(1):36-42. PubMed ID: 29320899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-itraconazole interaction: possible mechanisms.
    Alderman CP; Allcroft PD
    Ann Pharmacother; 1997 Apr; 31(4):438-40. PubMed ID: 9101006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition.
    Ballent M; Lifschitz A; Virkel G; Sallovitz J; Lanusse C
    J Vet Pharmacol Ther; 2007 Jun; 30(3):242-8. PubMed ID: 17472656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of probenecid on the renal and biliary clearances of digoxin in man.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Br J Clin Pharmacol; 1991 Jul; 32(1):63-7. PubMed ID: 1888643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of itraconazole metabolites in CYP3A4 inhibition.
    Isoherranen N; Kunze KL; Allen KE; Nelson WL; Thummel KE
    Drug Metab Dispos; 2004 Oct; 32(10):1121-31. PubMed ID: 15242978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers.
    Mant T; Fournié P; Ollier C; Donat F; Necciari J
    Clin Pharmacokinet; 2002; 41 Suppl 2():39-45. PubMed ID: 12383044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier.
    Miyama T; Takanaga H; Matsuo H; Yamano K; Yamamoto K; Iga T; Naito M; Tsuruo T; Ishizuka H; Kawahara Y; Sawada Y
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1738-44. PubMed ID: 9661014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.